Analysts think APM stock price could increase by 1717%
Jun 14, 2024, 6:29 AM
6.68%
What does APM do
Aptorum Group Ltd. is a pharmaceutical company focused on developing therapeutic assets for diseases with unmet medical needs, especially in oncology and infectious diseases. The company operates in two segments: Therapeutics, advancing drug molecules like ALS-4 for infectious diseases and SACT-1 for cancer, and Non-Therapeutics, which includes diagnostics and natural supplements.
2 analysts think APM stock price will increase by 1717.37%. The current median analyst target is $81.60 compared to a current stock price of $4.49. The lowest analysts target is $80.80 and the highest analyst target is $84.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
